Author:
Hayama Tatsuya,Hayasaka Masatoshi,Onuma Mei,Nakayama Toshimitsu,Amano Sadao,Yoshida Yoshikazu
Publisher
Japanese Society of Pharmaceutical Health Care and Sciences
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference39 articles.
1. 1）Witherup KM, Look SA, Stasko MW, Ghiorzi TJ, Muschik GM, Cragg GM, Taxus spp, needles contain amounts of taxol comparable to the bark of Taxus brevifolia: analysis and isolation, J Nat Pro, 1990, 5, 1249-1255.
2. 2）Kubota K, Watanabe K, Kunitoh H, Noda K, Ichinose Y, Katakami N, Sugiura T, Kawahara M, Yokoyama A, Yokota S, Yoneda S, Matsui K, Kudo S, Shibuya M, Isobe T, Segawa Y, Nishiwaki Y, Ohashi Y, and Niitani H, Phase III Randomized Trial of Docetaxel Plus Cisplatin Versus Vindesine Plus Cisplatin in Patients With Stage IV Non-Small-Cell Lung Cancer: The Japanese Taxotere Lung Cancer Study Group, J Clin Oncol, 2004, 2, 254-261.
3. 3）Jones S, Holmes FA, O’Shaughnessy J, Blum JL, Vukelja SJ, McIntyre KJ, Pippen JE, Bordelon JH, Kirby RL, Sandbach J, Hyman WJ, Richards DA, Mennel RG, Boehm KA, Meyer WG, Asmar L, Mackey D, Riedel S, Muss H, Savin MA, Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735, J Clin Oncol, 2009, 8, 1177-1183.
4. 4）Polyzos A, Malamos N, Boukovinas I, Adamou A, Ziras N, Kalbakis K, Kakolyris S, Syrigos K, Papakotoulas P, Kouroussis C, Karvounis N, Vamvakas L, Christophyllakis C, Athanasiadis A, Varthalitis I, Georgoulias V, Mavroudis D, FEC versus sequential docetaxel followed by epirubicin/cyclophosphamide as adjuvant chemotherapy in womenwith axillary node-positive early breast cancer: a randomized study of the Hellenic Oncology Research Group (HORG), Breast Cancer Res Treat, 2010, 119, 95-104, Epub 2009 Jul 28.
5. 5）Taguchi T, Sakata Y, Kanamaru R, Kurihara M, Suminaga M, Ota J, Hirabayashi N, Late phase II clinical study of RP56976 (docetaxel) in patients with advanced/recurrent gastric cancer: a Japanese Cooperative Study Group trial (group A)], Gan To Kagaku Ryoho, 1998, 25, 1915-1924.